Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$696M |
| 2 |
Moderna
MRNA
|
+$487M |
| 3 |
Analog Devices
ADI
|
+$272M |
| 4 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$261M |
| 5 |
Tesla
TSLA
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$670M |
| 2 |
Microsoft
MSFT
|
+$376M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$335M |
| 4 |
Alibaba
BABA
|
+$323M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$272M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.45% |
| 2 | Healthcare | 13.43% |
| 3 | Financials | 12.56% |
| 4 | Consumer Discretionary | 10.66% |
| 5 | Communication Services | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Sonos
SONO
$1.93B
| $16.6M | ﹤0.01% |
512,536
+57,369
| +13% | +$2.07M |
|
1827
MYR Group
MYRG
$5.21B
| $16.6M | ﹤0.01% |
166,487
+771
| +0.5% | +$75.8K |
|
1828
Champion Homes
SKY
$5.13B
| $16.5M | ﹤0.01% |
275,403
+8,811
| +3% | +$522K |
|
1829
SFL Corp
SFL
$1.64B
| $16.5M | ﹤0.01% |
1,973,585
+33,131
| +2% | +$251K |
|
1830
Supernus Pharmaceuticals
SUPN
$2.81B
| $16.5M | ﹤0.01% |
617,120
+7,826
| +1% | +$210K |
|
|
ESGR
1831
DELISTED
Enstar Group
ESGR
| $16.4M | ﹤0.01% |
69,795
-4,658
| -6% | -$1.14M |
|
1832
Veracyte
VCYT
$3.32B
| $16.3M | ﹤0.01% |
351,554
+1,743
| +0.5% | +$76.1K |
|
|
OPTU
1833
Optimum Communications Inc
OPTU
$251M
| $16.3M | ﹤0.01% |
787,495
-278,857
| -26% | -$8.12M |
|
1834
ePlus
PLUS
$2.31B
| $16.3M | ﹤0.01% |
317,850
+3,390
| +1% | +$167K |
|
1835
EverQuote
EVER
$861M
| $16.3M | ﹤0.01% |
875,078
+1,943
| +0.2% | +$46.5K |
|
1836
Arvinas
ARVN
$587M
| $16.3M | ﹤0.01% |
197,996
+33,055
| +20% | +$2.92M |
|
|
ADAM
1837
Adamas Trust
ADAM
$910M
| $16.2M | ﹤0.01% |
953,510
+17,946
| +2% | +$312K |
|
1838
Rithm Capital
RITM
$5.79B
| $16.2M | ﹤0.01% |
1,476,186
-116,297
| -7% | -$1.19M |
|
|
DEN
1839
DELISTED
Denbury Inc.
DEN
| $16.2M | ﹤0.01% |
230,019
+1,795
| +0.8% | +$124K |
|
1840
Prudential
PUK
$34.7B
| $16.1M | ﹤0.01% |
411,318
-51,388
| -11% | -$1.99M |
|
|
GBIO
1841
DELISTED
Generation Bio
GBIO
| $16.1M | ﹤0.01% |
64,186
+1,979
| +3% | +$474K |
|
1842
Dime Commercial Bancshares
DCOM
$1.81B
| $16M | ﹤0.01% |
490,387
-11,616
| -2% | -$377K |
|
1843
Noble Corp
NE
$7.2B
| $16M | ﹤0.01% |
591,712
+23,753
| +4% | +$568K |
|
|
CLDR
1844
DELISTED
Cloudera, Inc.
CLDR
| $16M | ﹤0.01% |
1,001,414
-5,371,153
| -84% | -$85.2M |
|
1845
Sanofi
SNY
$105B
| $16M | ﹤0.01% |
331,583
+43,466
| +15% | +$2.21M |
|
1846
G-III Apparel Group
GIII
$1.43B
| $16M | ﹤0.01% |
564,048
-6,667
| -1% | -$201K |
|
|
PGRE
1847
DELISTED
Paramount Group
PGRE
| $16M | ﹤0.01% |
1,775,601
-124,658
| -7% | -$1.15M |
|
1848
Matthews International
MATW
$725M
| $15.9M | ﹤0.01% |
459,351
-2,909
| -0.6% | -$99.8K |
|
|
QVCGA
1849
DELISTED
QVC Group Inc Series A
QVCGA
| $15.9M | ﹤0.01% |
31,266
-3,505
| -10% | -$1.97M |
|
1850
Lantheus
LNTH
$6.59B
| $15.9M | ﹤0.01% |
620,082
+2,339
| +0.4% | +$61.1K |
|
Similar funds
Bank of New York Mellon's Q3 2021 Portfolio in Review
As of Q3 2021, Bank of New York Mellon held 4,634 positions worth $512B, down 0.89% from $517B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Bank of New York Mellon's Q3 2021 filing shows 243 new, 2,575 increased, 1,388 reduced and 114 closed positions. Its largest new stake was GXO Logistics: 863,863 shares worth $67.8M. The largest sale was Apple, an estimated $670M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q3 2021 buy was GXO Logistics: 863,863 shares worth $67.8M.
- Bank of New York Mellon added most to Vanguard S&P 500 ETF in Q3 2021, an estimated $696M increase.
- Bank of New York Mellon's biggest Q3 2021 reduction was Apple, cutting an estimated $670M.
- Bank of New York Mellon fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $335M.
- Bank of New York Mellon's ten largest holdings make up 20% of its $512B portfolio in Q3 2021.
- Bank of New York Mellon opened 243 new positions and closed 114 in Q3 2021.
- Bank of New York Mellon's portfolio value fell 0.89% quarter-over-quarter to $512B.
Based on Bank of New York Mellon's 13F filing for Q3 2021, filed 12 Nov 2021.